Non Pharmacological Management of Behavioural Symptoms in Nursing Home
NCT ID: NCT00824967
Last Updated: 2012-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
306 participants
INTERVENTIONAL
2007-10-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To evaluate the effectiveness of a staff education intervention to manage BPSD in older people with a diagnosis of dementia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use
NCT04820127
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
NCT04179721
Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes
NCT04327778
Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units
NCT01901263
Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)
NCT04481568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To evaluate the effectiveness of a staff education intervention to manage BPSD in older people with a diagnosis of dementia.
Methods: The trial was conducted in 16 nursing homes; 306 patients with a diagnosis of dementia and presenting BPSD were selected. Nursing homes were randomly allocated to an intervention group or a control group. An eight-week staff education and training programme was conducted in the nursing homes in the intervention group. The main outcome measures were the Cohen-Mansfield Agitation Inventory (CMAI) and an observation scale score. Assessments were done at baseline (W0), at the end of the 'intervention' period (W8) and 12 weeks after (W20).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1- The reference group
one will take care of the patient in a habitual way: no consultation additional, step of exam on top of that...
No interventions assigned to this group
2- The intervention group
Training and valuation of the treating personnel
Training and valuation of the treating personnel
Training and valuation of the treating personnel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training and valuation of the treating personnel
Training and valuation of the treating personnel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
60 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe ROBERT, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Nice - CM2R - Hôpital de Cimiez - 4 avenue reine victoria - 06 003 Nice cedex 1
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice - 4 avenue Reine Victoria
Nice, Alpes-Maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-PP-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.